These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1305694)

  • 1. Evaluation of DNA flow cytometry as a screening test for bladder cancer.
    deVere White RW; Deitch AD
    J Cell Biochem Suppl; 1992; 16I():80-4. PubMed ID: 1305694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DNA ploidy pattern of flow cytometry as indicator of malignancy and prognosis in bladder cancer].
    Hosaka Y
    Nihon Rinsho; 1992 Oct; 50(10):2426-31. PubMed ID: 1447813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Guérin therapy.
    Mengual L; Marín-Aguilera M; Ribal MJ; Burset M; Villavicencio H; Oliver A; Alcaraz A
    Eur Urol; 2007 Sep; 52(3):752-9. PubMed ID: 17379395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder.
    Giella JG; Ring K; Olsson CA; Karp FS; Benson MC
    J Urol; 1992 Aug; 148(2 Pt 1):293-6. PubMed ID: 1635121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality.
    Baak JP; Bol MG; van Diermen B; Janssen EA; Buhr-Wildhagen SB; Mestad O; Øgreid P; Kjellevold KH
    Urology; 2003 Jun; 61(6):1266-72. PubMed ID: 12809927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases.
    Bakhos R; Shankey TV; Flanigan RC; Fisher S; Wojcik EM
    Diagn Cytopathol; 2000 Feb; 22(2):65-9. PubMed ID: 10649514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of flow cytometric information in the clinical management of stage O (Ta) bladder cancer.
    deVere White RW; Deitch AD; West B; Fitzpatrick JM
    J Urol; 1988 Feb; 139(2):279-82. PubMed ID: 3339725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
    Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
    J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder.
    Slaton JW; Dinney CP; Veltri RW; Miller CM; Liebert M; O'Dowd GJ; Grossman HB
    J Urol; 1997 Sep; 158(3 Pt 1):806-11. PubMed ID: 9258087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by serial flow cytometry.
    Badalament RA; Gay H; Whitmore WF; Herr HW; Fair WR; Oettgen HF; Melamed MR
    Cancer; 1986 Dec; 58(12):2751-7. PubMed ID: 3779622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acridine-orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder. The influence of prior local therapy.
    Têtu B; Katz RL; Kalter SP; von Eschenbach AC; Barlogie B
    Cancer; 1987 Oct; 60(8):1815-22. PubMed ID: 3652008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive molecular detection of bladder cancer recurrence.
    Amira N; Mourah S; Rozet F; Teillac P; Fiet J; Aubin P; Cortesse A; Desgrandchamps F; Le Duc A; Cussenot O; Soliman H
    Int J Cancer; 2002 Sep; 101(3):293-7. PubMed ID: 12209982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometry versus urinary cytology in the diagnosis and follow-up of bladder tumors: critical review of a 5-year experience.
    Billerey C; Lamy B; Bittard H; Rozan S; Carbillet JP
    World J Urol; 1993; 11(3):156-60. PubMed ID: 8401634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA flow cytometry and bladder irrigation cytology in detection of bladder carcinoma.
    Kumar NU; Dey P; Mondal AK; Singh SK; Vohra H
    Diagn Cytopathol; 2001 Mar; 24(3):153-6. PubMed ID: 11241896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
    Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
    Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting disease outcome of non-invasive transitional cell carcinoma of the urinary bladder using an artificial neural network model: results of patient follow-up for 15 years or longer.
    Fujikawa K; Matsui Y; Kobayashi T; Miura K; Oka H; Fukuzawa S; Sasaki M; Takeuchi H; Okabe T
    Int J Urol; 2003 Mar; 10(3):149-52. PubMed ID: 12622711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder transitional cell carcinomas: a comparative study of washing and tumor bioptic samples by DNA flow cytometry and FISH analyses.
    Eleuteri P; Grollino MG; Pomponi D; Guaglianone S; Gallucci M; De Vita R
    Eur Urol; 2000 Mar; 37(3):275-80. PubMed ID: 10720852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of cytofluorometry in bladder tumors].
    Verine JL; Coic H; Bertrand G; Lépinard V; Soret JY
    Ann Urol (Paris); 1986; 20(3):175-85. PubMed ID: 3729300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry: role in monitoring transitional cell carcinoma of bladder.
    deVere White RW; Olsson CA; Deitch AD
    Urology; 1986 Jul; 28(1):15-20. PubMed ID: 3727223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.